Fidelity Investments’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.4M | Buy |
1,753,843
+1,575,411
| +883% | +$22.6M | ﹤0.01% | 1695 |
|
|
2025
Q4 | $2.54M | Sell |
178,432
-325,341
| -65% | -$3.2M | ﹤0.01% | 2521 |
|
|
2025
Q3 | $3.97M | Buy |
503,773
+83,564
| +20% | +$595K | ﹤0.01% | 2315 |
|
|
2025
Q2 | $2.41M | Buy |
420,209
+33,314
| +9% | +$215K | ﹤0.01% | 2429 |
|
|
2025
Q1 | $3.16M | Buy |
386,895
+115,944
| +43% | +$1.07M | ﹤0.01% | 2306 |
|
|
2024
Q4 | $2.55M | Sell |
270,951
-531,105
| -66% | -$5.52M | ﹤0.01% | 2365 |
|
|
2024
Q3 | $8.57M | Sell |
802,056
-236,251
| -23% | -$2.57M | ﹤0.01% | 1973 |
|
|
2024
Q2 | $10.3M | Sell |
1,038,307
-709,239
| -41% | -$7.28M | ﹤0.01% | 1864 |
|
|
2024
Q1 | $20.6M | Sell |
1,747,546
-446,914
| -20% | -$5.72M | ﹤0.01% | 1646 |
|
|
2023
Q4 | $31.1M | Sell |
2,194,460
-583,772
| -21% | -$6.63M | ﹤0.01% | 1470 |
|
|
2023
Q3 | $33.8M | Buy |
2,778,232
+468,611
| +20% | +$6.04M | ﹤0.01% | 1393 |
|
|
2023
Q2 | $29M | Buy |
2,309,621
+102,383
| +5% | +$1.21M | ﹤0.01% | 1482 |
|
|
2023
Q1 | $24.5M | Sell |
2,207,238
-284,410
| -11% | -$3.51M | ﹤0.01% | 1535 |
|
|
2022
Q4 | $30.4M | Sell |
2,491,648
-302,420
| -11% | -$3.4M | ﹤0.01% | 1460 |
|
|
2022
Q3 | $29.2M | Buy |
2,794,068
+744,451
| +36% | +$8.29M | ﹤0.01% | 1473 |
|
|
2022
Q2 | $22M | Buy |
2,049,617
+338,528
| +20% | +$2.79M | ﹤0.01% | 1611 |
|
|
2022
Q1 | $16.2M | Buy |
1,711,089
+111,257
| +7% | +$1.04M | ﹤0.01% | 1886 |
|
|
2021
Q4 | $18.5M | Buy |
1,599,832
+295,700
| +23% | +$3.3M | ﹤0.01% | 1863 |
|
|
2021
Q3 | $12.5M | Hold |
1,304,132
| – | – | ﹤0.01% | 2030 |
|
|
2021
Q2 | $12.6M | Buy |
1,304,132
+748,320
| +135% | +$7.3M | ﹤0.01% | 2017 |
|
|
2021
Q1 | $5.49M | Sell |
555,812
-3,148,143
| -85% | -$48.7M | ﹤0.01% | 2237 |
|
|
2020
Q4 | $85.5M | Sell |
3,703,955
-689,233
| -16% | -$14.1M | 0.01% | 1102 |
|
|
2020
Q3 | $62M | Sell |
4,393,188
-3,555,083
| -45% | -$51.8M | 0.01% | 1109 |
|
|
2020
Q2 | $120M | Sell |
7,948,271
-119,537
| -1% | -$1.46M | 0.01% | 808 |
|
|
2020
Q1 | $74.5M | Buy |
8,067,808
+6,240,121
| +341% | +$59.3M | 0.01% | 872 |
|
|
2019
Q4 | $17.8M | Sell |
1,827,687
-978,347
| -35% | -$8.96M | ﹤0.01% | 1641 |
|
|
2019
Q3 | $22.5M | Sell |
2,806,034
-4,159,681
| -60% | -$45.1M | ﹤0.01% | 1527 |
|
|
2019
Q2 | $86.9M | Sell |
6,965,715
-8,214,145
| -54% | -$104M | 0.01% | 975 |
|
|
2019
Q1 | $206M | Sell |
15,179,860
-2,763,663
| -15% | -$33.8M | 0.02% | 635 |
|
|
2018
Q4 | $172M | Buy |
17,943,523
+4,479,743
| +33% | +$49.2M | 0.02% | 642 |
|
|
2018
Q3 | $163M | Sell |
13,463,780
-10,515
| -0.1% | -$147K | 0.02% | 742 |
|
|
2018
Q2 | $210M | Sell |
13,474,295
-4,060
| -0% | -$61.4K | 0.02% | 644 |
|
|
2018
Q1 | $203M | Sell |
13,478,355
-4,505,176
| -25% | -$68.6M | 0.02% | 677 |
|
|
2017
Q4 | $259M | Sell |
17,983,531
-1,332,286
| -7% | -$18.3M | 0.03% | 592 |
|
|
2017
Q3 | $291M | Sell |
19,315,817
-2,121,691
| -10% | -$28.1M | 0.04% | 529 |
|
|
2017
Q2 | $216M | Buy |
21,437,508
+705,153
| +3% | +$5.67M | 0.03% | 658 |
|
|
2017
Q1 | $148M | Sell |
20,732,355
-616,574
| -3% | -$3.9M | 0.02% | 826 |
|
|
2016
Q4 | $106M | Buy |
21,348,929
+28,066
| +0.1% | +$194K | 0.01% | 963 |
|
|
2016
Q3 | $158M | Buy |
21,320,863
+2,297,810
| +12% | +$15.5M | 0.02% | 784 |
|
|
2016
Q2 | $104M | Buy |
19,023,053
+299,950
| +2% | +$2.1M | 0.01% | 949 |
|
|
2016
Q1 | $158M | Sell |
18,723,103
-11,812
| -0.1% | -$83.7K | 0.02% | 761 |
|
|
2015
Q4 | $182M | Buy |
18,734,915
+3,939,946
| +27% | +$35.5M | 0.02% | 701 |
|
|
2015
Q3 | $207M | Buy |
14,794,969
+1,694,621
| +13% | +$26.6M | 0.03% | 615 |
|
|
2015
Q2 | $185M | Buy |
13,100,348
+12,538,144
| +2,230% | +$151M | 0.02% | 737 |
|
|
2015
Q1 | $6.12M | Hold |
562,204
| – | – | ﹤0.01% | 2161 |
|
|
2014
Q4 | $4.68M | Hold |
562,204
| – | – | ﹤0.01% | 2253 |
|
|
2014
Q3 | $3.35M | Hold |
562,204
| – | – | ﹤0.01% | 2320 |
|
|
2014
Q2 | $1.88M | Hold |
562,204
| – | – | ﹤0.01% | 2420 |
|
|
2014
Q1 | $1.16M | Hold |
562,204
| – | – | ﹤0.01% | 2458 |
|
|
2013
Q4 | $1.32M | Sell |
562,204
-220,179
| -28% | -$483K | ﹤0.01% | 2411 |
|
|
2013
Q3 | $1.81M | Sell |
782,383
-488,939
| -38% | -$1.23M | ﹤0.01% | 2362 |
|
|
2013
Q2 | $2.96M | Buy |
+1,271,322
| New | +$3.91M | ﹤0.01% | 2248 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Fidelity Investments's FOLD Position: Q1 2026 in Review
Fidelity Investments increased its Amicus Therapeutics (FOLD) stake by 883% in Q1 2026, buying an estimated $22.6M and bringing the position to 1,753,843 shares worth $25.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1695.
Fidelity Investments first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. The position peaked at $291M in Q3 2017. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Fidelity Investments held 1,753,843 shares of Amicus Therapeutics worth $25.4M as of Q1 2026.
- Fidelity Investments bought 1,575,411 Amicus Therapeutics shares in Q1 2026, an estimated $22.6M.
- Amicus Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1695 holding.
- Fidelity Investments first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Amicus Therapeutics position peaked at $291M in Q3 2017.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.